Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Rivaroxaban: Xarelto--recommendations for pharmacists].
Douxfils J, Michel S, Beauloye C, Goethals M, Hainaut P, Heidbuchel H, Hermans C, Ickx B, Jochmans K, Mottes S, Mullier F, Peeters A, Scavée C, Sinnaeve P, Sprynger M, Thijs V, Vandenbroeck C, Vandermeulen E, Verhamme P, Dogné JM. Douxfils J, et al. Among authors: hainaut p. J Pharm Belg. 2013 Mar;(1):28-36. J Pharm Belg. 2013. PMID: 23638610 French.
Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.
Douxfils J, Buckinx F, Mullier F, Minet V, Rabenda V, Reginster JY, Hainaut P, Bruyère O, Dogné JM. Douxfils J, et al. Among authors: hainaut p. J Am Heart Assoc. 2014 Jun 6;3(3):e000515. doi: 10.1161/JAHA.113.000515. J Am Heart Assoc. 2014. PMID: 24906369 Free PMC article. Review.
The Impact of Strong Inducers on Direct Oral Anticoagulant Levels.
Sennesael AL, Larock AS, Hainaut P, Lessire S, Hardy M, Douxfils J, Spinewine A, Mullier F. Sennesael AL, et al. Among authors: hainaut p. Am J Med. 2021 Oct;134(10):1295-1299. doi: 10.1016/j.amjmed.2021.06.003. Epub 2021 Jun 25. Am J Med. 2021. PMID: 34181907
[Dyspnea in a 64 year-old woman].
Pothen L, Yildiz H, Aydin S, Camboni A, Lambert M, Hainaut P, Ebbo M. Pothen L, et al. Among authors: hainaut p. Rev Med Interne. 2020 Jan;41(1):58-61. doi: 10.1016/j.revmed.2019.06.009. Epub 2019 Jul 13. Rev Med Interne. 2020. PMID: 31311673 French. No abstract available.
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
Agnelli G, Hoffmann U, Hainaut P, Gaine S, Ay C, Coppens M, Schindewolf M, Jimenez D, Brüggenjürgen B, Levy P, Laeis P, Fronk EM, Zierhut W, Malzer T, Manu MC, Reimitz PE, Bramlage P, Cohen AT; ETNA-VTE-Europe investigators. Agnelli G, et al. Among authors: hainaut p. Thromb Res. 2020 Dec;196:297-304. doi: 10.1016/j.thromres.2020.09.001. Epub 2020 Sep 12. Thromb Res. 2020. PMID: 32950897
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
Cohen AT, Ay C, Hainaut P, Décousus H, Hoffmann U, Gaine S, Coppens M, da Silva PM, Castro DJ, Amann-Vesti B, Brüggenjürgen B, Levy P, Bastida JL, Vicaut E, Laeis P, Fronk EM, Zierhut W, Malzer T, Bramlage P, Agnelli G; ETNA-VTE-Europe investigators. Cohen AT, et al. Among authors: hainaut p. Thromb J. 2018 May 1;16:9. doi: 10.1186/s12959-018-0163-7. eCollection 2018. Thromb J. 2018. PMID: 29719492 Free PMC article.
473 results